Blog
Why Cognitive Decline Isn’t Inevitable And What to Do About It: The Neuroprotective Interventions With the Strongest Evidence
Most people don’t think about cognitive decline until they notice it. A name they can’t retrieve or a conversation where the word they need takes three seconds to arrive. By the time these symptoms are noticeable, the underlying process has been developing for years. Neurological aging — like most forms of biological aging — is primarily a silent condition. The window for intervention isn’t when you’re symptomatic. It’s before you are.
Here’s what the research increasingly shows:
- Cognitive decline is not an inevitable consequence of aging. It’s a consequence of specific, measurable biological processes — many of which are addressable.
- The people who maintain cognitive sharpness into their seventies and eighties aren’t simply lucky. They’ve preserved the biological environment that neurological function depends on.
The Mechanisms Behind Cognitive Aging
Understanding what drives cognitive decline points directly to what prevents it.
Mitochondrial Failure and NAD+ Depletion
The brain is the most metabolically demanding organ in the body — consuming roughly twenty percent of the body’s energy despite representing only two percent of its mass. That energy comes from mitochondrial ATP production, which is entirely dependent on NAD+ availability.
NAD+ levels decline approximately fifty percent between age forty and sixty, and continue declining. For the brain, this translates to reduced neuronal energy production, impaired DNA repair in neural tissue, and reduced activity of sirtuins — the protein family most associated with cellular longevity and neuroprotection.
The cognitive symptoms of NAD+ depletion — mental fatigue, slower processing speed, difficulty with sustained concentration — often appear years before they’re recognized as neurological rather than simply aging.
Systemic Inflammation — the Brain Under Attack
The blood-brain barrier is permeable to inflammatory cytokines. When systemic inflammation is chronically elevated — as it commonly is in adults over sixty with untreated metabolic, cardiovascular, or hormonal conditions — the neuroinflammatory load increases. Elevated IL-6 and TNF-alpha have been directly linked to reduced neurogenesis, impaired synaptic function, and accelerated cognitive aging.
This is why addressing systemic inflammation isn’t just a cardiovascular or joint concern. It’s a cognitive protection strategy.
Homocysteine — the Overlooked Neurotoxin
Elevated homocysteine is one of the most consistent and actionable findings in people with cognitive decline risk. It’s a direct neurotoxin — damaging arterial walls, impairing blood flow to the brain, and accelerating hippocampal atrophy. It’s also almost entirely correctable through targeted B-vitamin and methylation support.
Despite this, homocysteine isn’t measured on standard annual panels. LIVV runs it as part of every comprehensive cognitive panel.
Hormonal Depletion
Testosterone and estrogen have direct neuroprotective effects — independent of their more commonly discussed roles in physical performance and body composition. Testosterone supports myelin integrity and cognitive processing speed. Estrogen modulates serotonin and dopamine pathways, supports verbal memory, and has significant evidence for delaying the onset of Alzheimer’s-related pathology when maintained during the menopausal transition.
The cognitive decline that many people attribute to “just aging” is frequently, in significant part, hormonal depletion that was never addressed.
Neuroprotective Interventions at LIVV Cardiff With the Strongest Evidence
NAD+ IV Infusions
Intravenous NAD+ delivers the compound at the intracellular concentration that oral supplementation frequently fails to achieve. For the brain specifically, direct NAD+ repletion supports:
- Neuronal energy production
- DNA repair in neural tissue
- Sirtuin activation and mitochondrial biogenesis
- Cognitive clarity and processing speed
Clinical reports and growing research consistently document improvements in mental clarity, focus, and energy in the weeks following regular NAD+ infusion protocols. For individuals over sixty, this is often the most immediately perceptible intervention in a longevity protocol.
Cerebrolysin
Cerebrolysin is a neuropeptide complex derived from porcine brain protein — and it has the strongest published clinical evidence of any compound in the cognitive protection category. It has been used clinically for neurological conditions including stroke, traumatic brain injury, and Alzheimer’s in Eastern Europe and Asia for over thirty years, with an extensive clinical literature.
For healthy aging adults with cognitive concerns, Cerebrolysin:
- Upregulates BDNF (brain-derived neurotrophic factor), the primary growth factor for neuronal maintenance and neurogenesis
- Protects neurons from oxidative and inflammatory damage
- Supports synaptic plasticity and cognitive processing efficiency
- Has demonstrated neuroprotective effects in multiple randomized controlled trials
In a longevity context, Cerebrolysin is deployed not as treatment for existing pathology but as neuroprotection before it’s needed — the cognitive equivalent of treating cardiovascular risk markers before a cardiac event.
Semax
Semax is a synthetic peptide derived from ACTH — a hormone involved in stress response and cognitive function. Its primary mechanism is BDNF upregulation and neuroprotection, with secondary effects on focus, mental processing speed, and neurological resilience under cognitive load.
Where Cerebrolysin provides structural neuroprotection, Semax addresses the functional cognitive dimension — the speed, clarity, and resilience that people notice most directly in their daily experience.
HBOT (Hyperbaric Oxygen Therapy) — Brain Health Evidence
A 2020 study published in Aging (Shabsai et al., Tel Aviv University) found that an HBOT protocol produced:
- Significant telomere elongation
- Significant reduction in senescent cell burden
- Improved cognitive performance on measures of attention and information processing speed
For brain health specifically, HBOT increases cerebral blood flow, supports neurogenesis, reduces neuroinflammation, and enhances mitochondrial function in neural tissue. It’s one of the few interventions with evidence for both structural (cellular aging) and functional (cognitive performance) neuroprotection simultaneously.
Hormonal Optimization
For men: testosterone optimization to the upper-optimal range supports cognitive processing speed, verbal fluency, and the drive and motivation that are frequently the earliest functional signs of hormonal decline.
For women: maintained estradiol and progesterone through the menopause transition and beyond has consistent evidence for protecting verbal memory, executive function, and mood stability — as well as reducing Alzheimer’s risk in the long-term data.
These are not peripheral considerations. Hormonal optimization is cognitive protection.
The Case for Acting Before You’re Symptomatic
Neurological aging research consistently shows that the biological changes driving cognitive decline begin ten to twenty years before they become clinically apparent. The plaques, tangles, and neuroinflammatory patterns associated with Alzheimer’s have been detected in individuals who were cognitively normal at time of measurement — and who went on to develop clinical disease years later.
The window for neuroprotective action is not when cognitive symptoms appear. It’s in the decades before they do — when the biological environment can be actively shaped, and when the interventions available have their greatest effect.